U-Blot® Research Grade OrforglipronCat. No. WA3304Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade OrforglipronCat. No. WA3304
U-Blot® Research Grade OregovomabCat. No. WA3303
U-Blot® Research Grade ordastobartCat. No. WA3302
U-Blot® Research Grade OpugotamigCat. No. WA3301
U-Blot® Research Grade OpucolimabCat. No. WA3300
U-Blot® Research Grade OportuzumabCat. No. WA3299
U-Blot® Research Grade OpinerceptCat. No. WA3298
U-Blot® Research Grade OpicinumabCat. No. WA3297
U-Blot® Research Grade OpelkibartCat. No. WA3296
U-Blot® Research Grade opamtistomigCat. No. WA3295
U-Blot® Research Grade onvontatugCat. No. WA3294
U-Blot® Research Grade OnvatilimabCat. No. WA3293